fashion -WSS

fashion

author：leisure time 2025-09-09 19:28:15 - browse：81

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Ionis drug prevents swelling attacks due to hereditary angioedema

hotspot

WSS

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

FDA's Pazdur wants cancer trials to range beyond China alone

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Activists slam private health insurers over coverage restrictions

ASCO: Palliative care found as helpful given virtually as in person

Activists slam private health insurers over coverage restrictions

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

How to save PrEP access — and even expand it

FDA's Pazdur wants cancer trials to range beyond China alone

Moonlake's readout produced a cash windfall. Risks remain

Elon Musk announces 'temporary limits' for reading Twitter posts

The high cost of giving birth even with insurance

Greece's new parliament sworn in following conservative party's election victory

focus

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Churchill Downs extends trainer Bob Baffert's ban through 2024

Shifting the focus from loneliness to social health

Elon Musk announces 'temporary limits' for reading Twitter posts

Wikipedia

hotspot

leisure time

leisure time